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life in atopic dermatitis (AD) and a generic quality of life measure
and from this use optimised algorithms to estimate health utility.
METHODS: Multinomial logistic regression was used to esti-
mate response probabilities to the SF-12 health survey from
responses to the Dermatology Life Quality Index (DLQI) in
patients enrolled into a clinical trial studying the long-term use
of tacrolimus ointment. A random sample of 70% of patient
responses was used for the regression analysis, with the remain-
ing 30% used to test the predictive ability of the response
mapping. Predicted and actual SF-12 responses were converted
to SF-6D and EQ-5D health utilities using published algorithms
(Brazier 2004 and Gray 2006) by Monte Carlo simulation.
RESULTS: Evaluable data were available for 255 patients, 40%
of whom were male, and for which the median age at screening
was 28 years (IQR 22 to 38). The percentage of variance in item
response attributable to predictor variable change ranged 15.6%
(SFCALM) to 33.3% (SFLESS). The mean predicted utility in the
test dataset was 0.797 (sd 0.092) by the SF-6D method and 0.787
(0.210) by EQ-5D. The mean squared error (MSE) between the
actual and predicted utilities were 0.013 for SF-6D and 0.068 for
EQ-5D. Predicted SF-6D utility was within 10% of the actual
utility in 62.7% of cases while for predicted EQ-5D utility this
fell to 39.8%. CONCLUSION: Response mapping of disease-
speciﬁc quality of life in AD to generic quality of life SF-12
produced more reliable estimates of SF-6D utility than EQ-5D
utility, and correlated closely with similar estimates made from a
standard assessment of disease severity in eczema.
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OBJECTIVE: To develop a patient self-administered question-
naire assessing the added value of complete independence from
glasses in patients after multifocal intraocular lens surgery.
METHODS: A qualitative study was performed to develop the
questionnaire. Exploratory interviews with ﬁve cataract patients
and six presbyopia patients with ReSTOR® implanted in both
eyes for at least 6 months were conducted. After interview analy-
sis, a conceptual model was developed. Items were generated
simultaneously in French and Spanish based on the identiﬁed
concepts and using patients’ own words. Six patients completed
the French test questionnaire and provided comments regarding
questionnaire’s structure and content. The questionnaire was
reﬁned. The Spanish test questionnaire then underwent a clini-
cian review and was tested with four patients. Test versions were
reﬁned and the French and Spanish pilot versions of the ques-
tionnaire were subsequently produced. RESULTS: Nine global
concepts were included in the conceptual model: global vision,
practical constraints related to wearing glasses, impact of eye
surgery on patient’s life, improvement of the practical issues
without glasses, improvement of the psychological constraints
without glasses, physical appearance / aesthetic aspect (self-
image and in the eyes of the others), surgery left behind, recom-
mendation of surgery to others. The ﬁrst version of the test
questionnaire contained 26 items. After the test with French
patients, two items were deleted. The Spanish test questionnaire
was modiﬁed accordingly. Minor additional changes were
brought after clinician review and patient tests of the Spanish
version. The ﬁnal questionnaire named ‘Freedom from Glasses
Value Scale (FGVS©)’ contained 21 items and four general addi-
tional questions. CONCLUSION: Beyond functional aspects,
this qualitative study identiﬁed additional beneﬁts in cataract
and presbyopic patients’ living free of glasses after receiving
ReSTOR®. The FGVS© will allow these beneﬁts to be assessed.
It is available in French and Spanish. UK English and Danish
linguistically validated versions are also available.
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OBJECTIVE: The purpose of this study was to conduct a
statistical mapping between standard assessments of disease
severity in atopic dermatitis (AD) and a generic quality of life
measure and use optimised algorithms to estimate health utility.
METHODS: Multinomial logistic regression was used to esti-
mate response probabilities to the SF-12 health survey from
assessment of AD severity using the modiﬁed Eczema Area &
Severity Index (mEASI) in patients enrolled into a clinical trial
studying the long-term use of tacrolimus ointment. A random
sample of 70% of patient responses was used for the regression
analysis, with the remaining 30% used to test the predictive
ability of the response mapping. Predicted and actual SF-12
responses were converted to SF-6D and EQ-5D health utilities
using published algorithms (Brazier 2004 and Gray 2006) by
Monte Carlo simulation. RESULTS: Evaluable data were avail-
able for 255 patients, 40% of whom were male, and for which
the median age at screening was 28 years (IQR 22 to 38). The
percentage of variance in item response attributable to predictor
variable change ranged from 19.8% (SFCALM) to 37.5%
(SFENER). The mean predicted utility in the test dataset was
0.799 (sd 0.083) by the SF-6D method and 0.778 (0.203) by
EQ-5D. The mean squared error (MSE) between the actual and
predicted utilities were 0.012 for SF-6D and 0.075 for EQ-5D.
Predicted SF-6D utility was within 10% of the actual utility in
64.8% of cases while for predicted EQ-5D utility this fell to
39.9%. CONCLUSION: In this study response mapping of AD
symptom severity to SF-12 produced more reliable estimates of
SF-6D utility than EQ-5D utility. In young adults with low
co-morbidity the sensitivity of SF-6D at higher utilities make it
be a more appropriate choice than EQ-5D where cases would
otherwise be classiﬁed in perfect health.
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OBJECTIVE: The measurement of oral health related QoL
(OHRQoL) is generally limited to dental diseases. Our objective
was to evaluate patients with oral mucosal diseases using an oral
health-speciﬁc questionnaire (OHIP-14), a generic health status
questionnaire (SF-12) and a general psychological health ques-
tionnaire (GHQ-12) to identify the possible presence of condi-
tions such as depression or anxiety. METHODS: Consecutive
patients coming to the oral health care unit of IDI-IRCCS in
Rome were asked to complete the OHIP-14, the SF-12, and the
GHQ-12 questionnaires. Both physicians and patients gave a
global assessment of severity of disease (PhGA and PtGA, respec-
tively) on a 5-point scale. Agreement between physiscians and
patients was assessed using Cohen’s K statistic. RESULTS: Of
218 patients contacted, 206 participated in the study. Oral ulcer-
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ations were the condition with the highest impact on OHRQoL.
Women had poorer OHRQoL and higher GHQ-12 scores than
males. There was a very strong correlation between question-
naires scores and PtGA, but none or very scarce between ques-
tionnaire scores and PhGA. The overall K between PtGA and
PhGA was 0.14, i.e., only slight, and for some conditions it was
even negative (e.g., -0.23 for non-malignant lesions). Patients
whose condition was “underestimated” by the physicians (i.e.,
PtGA>PhGA) had the worst OHRQoL and psychological status
among all patients in the study. CONCLUSION: The adminis-
tration of speciﬁc and generic questionnaires provides a complete
and clinically useful picture of the impact of oral diseases on
quality of life and on psychological well-being. The combined use
of PhGA and PtGA allows to deﬁne a group of patients with
particularly high levels of quality of life impairment and psycho-
logical distress. This may be relevant since these patient charac-
teristics have been linked to dissatisfaction with care, poorer
treatment adherence, and possibly higher probability of legal
litigation.
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OBJECTIVE: Cost-utility analysis is the preferred method of
economic evaluation to support health policy decision-making
in most developed nations. Utility estimation is based upon the
untested assumption that a single universal construct, “health
related quality of life” (HRQoL), is measured. We hypothesize
that this is the case with vision related diseases. We test whether
vision-related quality of life (VRQoL) is a distinct construct from
HRQoL using two instruments: the SF-36 to measure HRQoL,
and the NEI Vision Function Questionnaire (NEI-VFQ) to
measure VRQoL. METHODS: Over 16 months, 443 patients
from 18 ophthalmic practices were interviewed. The relationship
among item responses from the SF-36 and NEI-VFQ was
assessed using exploratory factor analysis (EFA) and variable
cluster analysis (VCA). RESULTS: The results suggest that vision
and non-vision related quality of life are indeed two distinct
constructs. In EFA, no items from the NEI-VFQ loaded on con-
structs formed by the SF-36 items, or vice-versa. Variable cluster
analysis conﬁrms the EFA, with the SF-36 and NEI-VFQ items
showing moderate correlation with items from their “home”
instrument, but weak correlation with items from the other
instrument. CONCLUSIONS: Our preliminary results provide
evidence that VRQoL and HRQoL are two distinct constructs
that have modest association. While these analyses are based
upon use of functional based measures as opposed to preference
based measures such as the standard gamble (SG) or time trade-
off (TTO), the results may have important implications for the
validity of preference based measures for assessment of effective-
ness. If the SG or TTO (or similar instruments) do not adequately
measure all aspects of health, interventions addressing poorly
measured problems (vision-related problems in this case) may be
substantially underestimated. If this is the case, health policy
makers relying on cost-effectiveness studies using these instru-
ments might incorrectly reject health programs for treatment of
important medical conditions.
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OBJECTIVES: To date, no model has explained the relationship
between the NEI-VFQ and health state utilities such as those
measured by the EQ-5D. Ordinary Least Square (OLS) is most
commonly used to identify association but it may not be appro-
priate in low vision. In this study, we evaluate different model
speciﬁcations to identify which better predicts the relative impor-
tance of the NEI-VFQ 25 dimensions on the EQ-5D index.
METHODS: We compare OLS and Tobit approach using cross-
sectional data (n = 155) at screening from a phase I/II clinical
trial in patients with neovascular age-related macular degenera-
tion (NV-AMD). We validate the models using a split-sample
technique and calculate each model’s mean predicted error and
standard error. Correlations between the predicted EQ-5D index
values derived from the NEI-VFQ 25 dimensions and the
observed EQ-5D index score are compared across models.
RESULTS: Mean prediction error from the Tobit model is lower
than the OLS approach (26 vs. 39 percent). The standard errors
of prediction of the Tobit and OLS models are 0.0263 and
0.0234, respectively. The predicted EQ-5D index value from
the Tobit model provides better correlation with the observed
EQ-5D index score compared to the OLS approach [Pearson
Correlation Coefﬁcients are 0.57 and 0.47, respectively]. CON-
CLUSION: In this situation, the Tobit model provides better
predictive accuracy than OLS for explaining the relationship
between the EQ-5D index and the NEI-VFQ 25. Tobit produces
consistent estimates of the relationship between the EQ-5D index
and the dimensions of the NEI-VFQ 25 by accounting for cen-
soring and ceiling effect problems. Although it is sensitive to
model misspeciﬁcation, adjusting for heteroscedasticity neverthe-
less allows it to perform better than OLS. Veriﬁcation of these
results using the model and a second dataset is warranted.
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OBJECTIVE: To determine the lost productivity of Canadian
patients with moderate to severe psoriasis. METHODS: Seventy-
nine consecutive Canadian dermatology patients were inter-
viewed and completed the Work Productivity and Activity
Impairment Questionnaire. The inclusion criteria were diagnosis
with moderate to severe psoriasis by the treating dermatologist;
19 year of age or older and currently receiving treatment for
psoriasis with either a biologic or alternative therapy such as
phototherapy, systemic or topical treatments. Patient interviews
and data collection occurred between September 21st, 2005 and
November 8th, 2005. RESULTS: Eighty-one percent of patients
reported working full-time. On average, 2.6 hours (6.8) (about
6% of total work hours) were lost from work per week due to
psoriasis-related events. When asked how much psoriasis
affected their productivity while working, individuals on average
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